𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suppressor-cell dysfunction in children with histiocytosis-X

✍ Scribed by B. T. Shannon; W. A. Newton


Book ID
105003530
Publisher
Springer
Year
1986
Tongue
English
Weight
1021 KB
Volume
6
Category
Article
ISSN
0271-9142

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Etoposide in the treatment of six childr
✍ Viana, Marcos Borato ;Oliveira, Benigna Maria ;Silva, Celia Maria ;Leite, Virgin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 548 KB

Six children received etoposide as the single agent for treatment of Langerhans cell histiocytosis (LCH; histiocytosis X). Five were less than 2 years old at diagnosis. All had multiorgan involvement; one had liver and pulmonary dysfunction. Two infants also had clinical signs of immune deficiency.

Neuropsychologic deficits in children wi
✍ Whitsett, Stan F.; Kneppers, Kirstie; Coppes, Max J.; Egeler, R. Maarten πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 2 views

Background. Manifestations of Langerhans cell histiocytosis (LCH) in children range from only a rash, to bony lesions accompanied by pain, to major organ disease. When the central nervous system (CNS) is affected, the LCH patient may exhibit signs and symptoms of hypothalamic and pituitary dysfuncti

β€œEtoposide in the treatment of six child
✍ Whitlock, James A. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

Viana et al. [I] described their experience with etoposide (VP-16) as initial therapy in the management of patients with Langerhans cell histiocytosis (LCH). However, caution should be used in advocating the use of an epipodophyllotoxin as the "drug of choice" for the treatment of this disorder. Alt